West Pharmaceutical Services Balance Sheet Health
Financial Health criteria checks 6/6
West Pharmaceutical Services has a total shareholder equity of $2.9B and total debt of $207.3M, which brings its debt-to-equity ratio to 7.2%. Its total assets and total liabilities are $3.8B and $886.5M respectively. West Pharmaceutical Services's EBIT is $748.1M making its interest coverage ratio -62.3. It has cash and short-term investments of $898.6M.
Key information
7.2%
Debt to equity ratio
US$207.30m
Debt
Interest coverage ratio | -62.3x |
Cash | US$898.60m |
Equity | US$2.87b |
Total liabilities | US$886.50m |
Total assets | US$3.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: WPS's short term assets ($2.0B) exceed its short term liabilities ($533.5M).
Long Term Liabilities: WPS's short term assets ($2.0B) exceed its long term liabilities ($353.0M).
Debt to Equity History and Analysis
Debt Level: WPS has more cash than its total debt.
Reducing Debt: WPS's debt to equity ratio has reduced from 14.5% to 7.2% over the past 5 years.
Debt Coverage: WPS's debt is well covered by operating cash flow (370.6%).
Interest Coverage: WPS earns more interest than it pays, so coverage of interest payments is not a concern.